Galena Biopharma Inc (NASDAQ:GALE)

2.73
Data as of 12:16pm ET
 -0.11 / -3.87%
Today’s Change
1.66
Today|||52-Week Range
7.77
-44.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$335.2M

Company Description

Galena Biopharma, Inc. is a biotechnology company focused on discovering, developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. It currently develops peptide antigenbased off the shelf cancer immunotherapies for potential application to treatment of large populations of cancer survivors. The company was founded by Craig Mello on April 3, 2006 and is headquartered in Portland, OR.

Contact Information

Galena Biopharma, Inc.
4640 SW Macadam Avenue
Portland Oregon 97239
P:(855) 855-4253
Investor Relations:
(503) 405-8258

Employees

Shareholders

Mutual fund holders9.02%
Other institutional20.54%
Individual stakeholders0.59%

Top Executives

Mark J. AhnPresident, Chief Executive Officer & Director
Mark W. SchwartzChief Operating Officer & Executive Vice President
Ryan DunlapSecretary, CAO, Finance Director & Controller
Brian L. HamiltonChief Medical Officer & Executive Vice President
Remy BernardaVice President-Marketing & Communications

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.